geant4 simulation of an ocular proton beam & benchmark against mc codes
DESCRIPTION
GEANT4 simulation of an ocular proton beam & benchmark against MC codes. D. R. Shipley, H. Palmans, C. Baker, A. Kacperek Monte Carlo 2005 Topical Meeting Chattanooga, Tennessee, USA 17 - 21 April 2005. Overview of talk. Introduction and advantages of proton therapy - PowerPoint PPT PresentationTRANSCRIPT
GEANT4 simulation of an ocular proton beam & benchmark against MC codes
D. R. Shipley, H. Palmans, C. Baker, A. Kacperek
Monte Carlo 2005 Topical Meeting
Chattanooga, Tennessee, USA
17 - 21 April 2005
Overview of talk
• Introduction and advantages of proton therapy • Typical low-energy clinical proton therapy facility
62 MeV ocular proton beam at the Clatterbridge Centre for Oncology (CCO), UK
• GEANT4 simulations• Dose distributions for full-energy and modulated CCO
beam line and comparison with measurement• Key physical processes and dose distributions for 50,
150, 250 MeV monoenergetic beams• Conclusions and future work
Introduction
• Proton therapy is on the increase due to commercial availability of turnkey facilities and reduced cost
• Main treatment site is eye (melanoma) but more and more deep seated tumours
• Dosimetry is not as well established as for x-ray therapy; NPL has research projects for improved proton dosimetry
• Monte Carlo is essential for studying dosimetry, detector perturbation factors, stopping powers, etc.
Background: Improved therapy using protons versus x-rays
0 2 4 6 8z (cm)
0
20
40
60
80
100
pd
d
X - 10 MV
modulated
p - 100 MeV
non-modulated
Tumour
Principle of range modulation
z
Dw
CCO proton beam line – treatment room
CCO proton beam line – GEANT4 (VRML)
GEANT4 simulations: general
• GEANT4 6.2.p02 with Low Energy EM Physics package (G4EMLOW 2.3).
• Physics processes:– ICRU 49 parameterisation: proton energy loss (EM interactions)– LHEP and HEP models: hadronic processes (non-elastic
nuclear interactions)– recommended for use in medical applications (?)
• Cuts– 0.02 mm in phantom (<< dose scoring region), 10 mm
elsewhere– minimize any dependencies of particle transport on geometry
GEANT4: CCO beam line
• HadronTherapy (GEANT4):– calculates dose distributions in a PMMA phantom for the CCO
beam line– derived from the HadronTherapy advanced example distributed with
GEANT4– depth dose and lateral dose distributions – modulated and full-energy (no mod wheel) beams
• Comparison with:– McPTRAN.RZ: Palmans, NPL (2005)
and MCNPX– Film and diode measurements
Depth and lateral dose distributions in PMMA: CCO full-energy beam
Depth dose
0
0.2
0.4
0.6
0.8
1
1.2
0.0 0.5 1.0 1.5 2.0 2.5
Radius (cm)
No
rmal
ised
do
se (
arb
. un
its)
Measured: Film (average)
GEANT4
0
0.2
0.4
0.6
0.8
1
1.2
0.0 0.5 1.0 1.5 2.0 2.5
Radius (cm)
No
rmal
ised
do
se (
arb
. un
its)
Measured 1: Diode (average)
Measured 2: Diode (average)
Measured 3: Film (average)
GEANT4
Lateral dose:
front face
Lateral dose:
0.5 x r0
0
1
2
3
4
5
6
1.0 1.5 2.0 2.5 3.0
Depth in PMMA (cm)
No
rmal
ised
do
se @
3m
m d
epth
(ar
b. u
nit
s)
McPTRAN.RZMeasured 1 (from [23])Measured 2MCNPXGEANT4
Depth and lateral dose distributions in PMMA: CCO modulated beam
Depth dose
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.0 1.5 2.0 2.5 3.0
Depth in PMMA (cm)
No
rmal
ised
do
se @
3m
m d
epth
(ar
b. u
nit
s)
GEANT4
McPTRAN.RZ
Measured (from [23])
MCNPX
Lateral dose:
front face
Lateral dose:
0.5 x r0
0.0
0.2
0.4
0.6
0.8
1.0
1.2
0.0 0.5 1.0 1.5 2.0 2.5
Radius (cm)
No
rmal
ised
do
se (
arb
. un
its)
Measured 1: Diode (average)
Measured 2: Diode (average)
Measured 3: Film (average)
GEANT4
0
0.2
0.4
0.6
0.8
1
1.2
0.0 0.5 1.0 1.5 2.0 2.5
Radius (cm)
No
rmal
ised
do
se (
arb
. un
its)
Measured: Film (average)
GEANT4
GEANT4: monoenergetic beams
• WaterPhantom (GEANT4)– calculates dose distributions in a water phantom for monoenergetic
pencil beams – depth dose : 200 cylindrical slabs on beam axis– radial dose : 100 annular rings (0.1 mm thick) at 0.5, 0.9 x r0– energy : scoring phase space data
at a plane – analysed with MATLAB– 50, 150, 250 MeV pencil proton beams
• Comparison with:– PTRAN: Berger, NIST (1993)– MCNPX v2.5d (beta): LANL (2004)– SRIM v2003.12: Ziegler (2003)
Influence of key processes on depth dose distributions
0
20
40
60
80
100
120
140
160
180
0.86 0.88 0.9 0.92 0.94 0.96 0.98 1 1.02z/r0
dE
/dx
(MeV
g-1
cm
2)
CSDA
0
20
40
60
80
100
120
140
160
180
0.86 0.88 0.9 0.92 0.94 0.96 0.98 1 1.02z/r0
dE
/dx
(MeV
g-1
cm
2)
CSDA
+ energy straggling
0
5
10
15
20
25
30
35
40
0.86 0.88 0.9 0.92 0.94 0.96 0.98 1 1.02z/r0
dE
/dx
(MeV
g-1
cm
2)
CSDA
+ energy straggling
0
5
10
15
20
25
30
35
40
0.86 0.88 0.9 0.92 0.94 0.96 0.98 1 1.02z/r0
dE
/dx
(MeV
g-1
cm
2)
CSDA
+ energy straggling
+ multiple scattering
0
5
10
15
20
25
30
35
40
0.86 0.88 0.9 0.92 0.94 0.96 0.98 1 1.02z/r0
dE
/dx
(MeV
g-1
cm
2)
CSDA
+ energy straggling
+ multiple scattering
+ nuclear interactions
0
5
10
15
20
25
30
35
40
0 0.2 0.4 0.6 0.8 1z/r0
dE
/dx
(MeV
g-1
cm
2)
CSDA
+ energy straggling
+ multiple scattering
+ nuclear interactions
Influence of key processes on lateral dose distributions
1E-03
1E-02
1E-01
1E+00
1E+01
1E+02
1E+03
1E+04
0.0 0.5 1.0 1.5 2.0
r (cm)
Do
se (
a.u
.)
CSDA
1E-03
1E-02
1E-01
1E+00
1E+01
1E+02
1E+03
1E+04
0.0 0.5 1.0 1.5 2.0
r (cm)
Do
se (
a.u
.)
CSDA
+ multiple scattering
1E-03
1E-02
1E-01
1E+00
1E+01
1E+02
1E+03
1E+04
0.0 0.5 1.0 1.5 2.0
r (cm)
Do
se (
a.u
.)
CSDA
+ multiple scattering
+ energy straggling
1E-03
1E-02
1E-01
1E+00
1E+01
1E+02
1E+03
1E+04
0.0 0.5 1.0 1.5 2.0
r (cm)
Do
se (
arb
. u
nit
s)
CSDA
+ multiple scattering
+ energy straggling
+ nuclear interactions
Depth dose distributions in water:monoenergetic beams
0
20
40
60
80
100
1.5 2 2.5Depth in water (cm)
Do
se p
er in
cid
ent
flu
ence
(MeV
cm
2 g
-1 p
er p
roto
n)
MCNPX-50MeV
GEANT4-50MeV
PTRAN-50MeV
SRIM-50MeV
0
10
20
30
40
10 12 14 16 18
Depth in water (cm)
Do
se p
er in
cid
ent
flu
ence
(MeV
cm
2 g
-1 p
er p
roto
n)
MCNPX-150MeV
GEANT4-150MeV
PTRAN-150MeV
SRIM-150MeV
0
5
10
15
20
25
25 30 35 40
Depth in water (cm)
Do
se p
er in
cid
ent
flu
ence
(MeV
cm
2 g
-1 p
er p
roto
n)
MCNPX-250MeV
GEANT4-250MeV
PTRAN-250MeV
50 MeV
150 MeV
250 MeV
Stopping power
Energy loss straggling
Nuclear interaction
GEANT4 ICRU 49(param. model)
Bohr / Vavilov / Landau
LHEP / HEP
MCNPX ICRU 49 Vavilov LA150
PTRAN ICRU 49 Vavilov ICRU 63
SRIM Ziegler et al. ? -
Lateral dose distributions in water:monoenergetic beams
0.1
1.0
10.0
100.0
1000.0
10000.0
100000.0
0.0 0.2 0.4 0.6 0.8
Radius (cm)
Do
se (
MeV
g
-1 p
er p
roto
n)
MCNPX-050MeV
MCNPX-150MeV
MCNPX-250MeV
GEANT-050MeV
GEANT-150MeV
GEANT-250MeV
PTRAN-050MeV
PTRAN-150MeV
PTRAN-250MeV
0.1
1.0
10.0
100.0
1000.0
10000.0
0.0 0.5 1.0 1.5 2.0
Radius (cm)
Do
se (
MeV
g
-1 p
er p
roto
n)
MCNPX-050MeV
MCNPX-150MeV
MCNPX-250MeV
GEANT4-050MeV
GEANT4-150MeV
GEANT4-250MeV
PTRAN-050MeV
PTRAN-150MeV
PTRAN-250MeV
0.5 x r0
0.9 x r0
Multiple scattering
Nuclear interaction
GEANT4 Lewis LHEP / HEP
MCNPX Goudsmit & Sanderson
LA150
PTRAN Molière ICRU 63
Summary and conclusions
• GEANT4: low-energy clinical proton beam (CCO):– full-energy beam:
• overestimates Bragg peak by ~20%
– modulated beam: • increasing depth dose profile with distinctive peak• sharper penumbra and ‘horns’ at edge of lateral dose profile
– some dependence on GEANT4 models, daily beam variations and type of detector
• GEANT4: monoenergetic proton beams (clinical energies)– different physical models (or their implementation) in the MC codes
give distinct differences in dose distributions at these energies– improvements in GEANT4 model used is still needed (or a better
physical model chosen)
Future work
• Proton stopping powers for clinical beams:– directly using Monte Carlo– from fluence spectra at depth
• Perturbation factors for detectors• Graphite-to-water conversion factors
– proton calorimetry (NPL)